Replies to post #104382 on Elite Pharmaceuticals Inc (ELTP)

[Couch]

Fair enough. Perhaps I threw up the wrong article then. This looks like the one I should've thrown up.

US Back Pain Market Approaches $23 Billion in 2018 - Anticipated Long-Acting,
Abuse-Resistant Opioids Drive Value

http://www.reuters.com/article/2009/03/23/idUS158167+23-Mar-2009+PRN20090323

The US back pain market for drug
treatment will be valued at almost $23 billion in 2018, according to US Back
Pain, a report released today by WWMR, Inc. Growth in this market will be
driven largely by the opioid agonist products that are currently in
development. Many of these are long-acting, abuse-resistant formulations that
are highly anticipated in the clinical community. If pipeline products
deliver on efficacy and safety, uptake is likely to be considerable and at
premium prices.